Webinars & Podcasts

Healthy Cells, Healthy Results: How to Improve Cell Line Development

Stable cell line development to generate biotherapeutic proteins with Chinese Hamster Ovary (CHO) cell lines has historically been a lengthy process thwarted by multiple cell culture pain points. Starting with the harsh conditions associated with cryopreservation and revival, cells can often take several days to recover and enter their exponential phase of growth. Next, following transfection, cells must survive single cell isolation to generate a clonal population. Finally, clones are required to adapt to shaking culture conditions and endure the sheer stress which accompanies this transition.

All in all, these cell line development stages amount to a huge amount of pressure on the CHO cells to adapt, all while maintaining high expression of a foreign protein. As a result, cells frequently suffer with low viable cell densities and viability, ramping up project costs and extending biotherapeutic production timelines.

To improve the health of CHO cells in the cell line development workflow, Advanced Instruments developed the InstiGRO™ CHO, InstiSHAKE™ CHO and InstiTHAW™ CHO reagents that are animal component-free cell culture supplements. While InstiGRO CHO and CHO PLUS supplements promote clonal outgrowth following single cell isolation, InstiSHAKE CHO helps cells to adapt to shaking culture conditions. Finally, InstiTHAW CHO can be used at both the start and end of the cell line development workflow to promote high cell viability during cryopreservation and revival of the parental and research cell banks.

In this webinar, attendees will explore the value of each of the Insti reagents and discover customer use cases. The presented data will demonstrate how to support CHO cell health throughout the cell line development process, helping to drive efficiencies needed to move towards Investigational New Drug (IND) submission.

Related Resources

Learn more by checking out our additional educational resources below.

Cell Line Development Case Study

Reducing the timeline by 30% to produce a monoclonal cell line expressing a clinical candidate bi-specific antibody

View

Cell Line Development Case Study

Successfully filing an IND using Solentim’s VIPS™ single cell cloning system

View

Cell Line Development Case Study

Doubling the Speed of Cell Line Development in a Large Pharmaceutical Company

View

Cell Line Development App Note

Enhancing Clonal Outgrowth: Optimal Strategies with InstiGRO® CHO PLUS

View

Cell Line Development App Note

Addressing Cell Line Development Bottlenecks Progressing from Conditioned Medium to InstiGRO Reagents

View

Cell Line Development App Note

Automated Evidence of Clonality

View

Cell Line Development Webinar

Early Glycan Screening: Key to High-Quality Biologics Development

View

Cell Line Development Webinar

Podcast Critical Bottlenecks and Breakthroughs in CLD

View

Cell Line Development Webinar

Addressing the Issue of Genomic Stability in iPSCs - A New Approach for Restoring Cell Lines

View

Cell Line Development Posters

Cell Line Development Inefficiencies and Streamlining the Clone Selection Process for Protein Biologic Production with the Solentim Ecosystem

View

Cell Line Development Posters

Addressing CLD Pain Points, Creating Efficiencies and Accelerating Biotherapeutic Development with Advanced Instruments Ecosystem

View

Cell Line Development Posters

Product In Action - OsmoTECH® HT Automated Micro-Osmometer

View

Cell Line Development Knowledge Center

Customer Success Story: Why Clean Cells Chose VIPS® PRO: The Need for Clonality & GMP Compatibility

View

Cell Line Development Knowledge Center

Imaging Complex Cell Morphology: Mesenchymal Stem Cells (MSCs)

View

Cell Line Development Knowledge Center

Exploring iPSC Matrices: A Comparative Study Exploring the Application of MatriClone­™

View